Variable cytotoxicity of diphtheria toxin 388-granulocyte-macrophage colony-stimulating factor fusion protein for acute myelogenous leukemia stem cells

By Feuring-Buske M.   Frankel A.   Gerhard B.   Hogge D.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1390-1400

Elsevier

Access to resources Recommend Favorite

Antibody Response to DT–GM, a Novel Fusion Toxin Consisting of a Truncated Diphtheria Toxin (DT) Linked to Human Granulocyte–Macrophage Colony Stimulating Factor (GM), during a Phase I Trial of Patients with Relapsed or Refractory Acute Myeloid Leukemia

By Hall P.D.   Virella G.   Willoughby T.   Atchley D.H.   Kreitman R.J.   Frankel A.E.  

Clinical Immunology, Vol. 100, Iss. 2, 2001-08 ,pp. : 191-197

Academic Press

Access to resources Recommend Favorite

Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex

By Ersvær Elisabeth   Hampson Peter   Wendelbo Øystein   Lord Janet M   Gjertsen Bjørn Tore   Bruserud Øystein  

Hematology, Vol. 12, Iss. 3, 2007-06 ,pp. : 199-207

Maney Publishing

Access to resources Recommend Favorite

Determination of Ras-GTP and Ras-GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomonocytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation

By Raepple D.  

Annals of Hematology, Vol. 88, Iss. 4, 2009-04 ,pp. : 319-324

Springer Publishing Company

Access to resources Recommend Favorite

Expression of CD86 in acute myelogenous leukemia is a marker of dendritic/monocytic lineage

By Re F.   Arpinati M.   Testoni N.   Ricci P.   Terragna C.   Preda P.   Ruggeri D.   Senese B.   Chirumbolo G.   Martelli V.   Urbini B.   Baccarani M.   Tura S.   Rondelli D.  

Experimental Hematology, Vol. 30, Iss. 2, 2002-02 ,pp. : 126-134

Elsevier

Access to resources Recommend Favorite